Cargando…
BRAF(V600E) mutation is not associated with central lymph node metastasis in all patients with papillary thyroid cancer: Different histological subtypes and preoperative lymph node status should be taken into account
The association between central lymph node metastasis (LNM) and risk factors, including the presence of the BRAF mutation, BRAF(V600E), in patients with papillary thyroid cancer (PTC) requires further investigation. A potent risk factor that can indicate LNM in different histological subtypes of PTC...
Autores principales: | Dong, Si-Yang, Zeng, Rui-Chao, Jin, Lang-Ping, Yang, Fan, Zhang, Xiang-Jian, Yao, Zhi-Han, Zhang, Xiao-Hua, Wang, Ou-Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5604127/ https://www.ncbi.nlm.nih.gov/pubmed/28943919 http://dx.doi.org/10.3892/ol.2017.6694 |
Ejemplares similares
-
BRAF V600E and lymph node metastases in papillary thyroid cancer
por: Chen, Pan, et al.
Publicado: (2020) -
Predictive Factors for Level V Lymph Node Metastases in Papillary Thyroid Carcinoma with BRAF(V600E) Mutation and Clinicopathological Features
por: Li, Gui-you, et al.
Publicado: (2020) -
Deep Small RNA Sequencing of BRAF V600E Mutated Papillary Thyroid Carcinoma With Lymph Node Metastasis
por: Yusof, Azliana Mohamad, et al.
Publicado: (2019) -
Association of BRAF gene and TSHR with cervical lymph node metastasis of papillary thyroid microcarcinoma
por: Zhou, Changxin, et al.
Publicado: (2019) -
Predicting factors of central lymph node metastasis and BRAF(V600E) mutation in Chinese population with papillary thyroid carcinoma
por: Zhou, Sheng Li, et al.
Publicado: (2021)